Drug use in the United Kingdom is among the highest reported in Western Europe and people who inject drugs (PWID) experience stark health inequalities, with increased morbidity and early mortality. This report explores infections, as well as associated risks and behaviours, among people who inject drugs in the UK to the end of 2019. It also presents preliminary data on the impact of COVID-19 on PWID and services in 2020.
Clinical Commissioning Policy Statement: Treatment of chronic hepatitis C in patients with cirrhosis
Download
This NHS England policy statement sets out the hepatitis treatments that will be routinely commissioned by NHS England for the treatment of chronic hepatitis in patients with cirrhosis. It also sets out how access to treatments will be organised with the setting up of Operational Delivery Networks from August 2015 and arrangements in the interim.
